
Xtant Medical
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $23,031 | $20,884 | $32,357 | $33,255 |
Gross Profit | 13,330 | 11,971 | 17,754 | 21,992 |
EBITDA | -8,290 | -1,929 | 4,135 | 3,630 |
EBIT | -8,798 | -2,463 | 2,316 | 2,469 |
Net Income | -9,413 | -3,089 | 57 | 1,308 |
Net Change In Cash | 23,031 | 20,884 | 32,357 | 33,255 |
Free Cash Flow | -7,555 | -2,308 | 4,985 | 4,182 |
Cash | 9,870 | 12,157 | 17,053 | 10,400 |
Basic Shares | 140,258 | 150,462 | 150,462 | 148,574 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $133,927 | $117,267 | $91,303 | $57,969 |
Gross Profit | 84,273 | 68,216 | 55,467 | 32,137 |
EBITDA | 15,895 | -7,878 | 5,075 | -5,428 |
EBIT | 10,672 | -12,102 | 1,901 | -6,724 |
Net Income | 4,973 | -16,449 | 660 | -8,485 |
Net Change In Cash | 133,927 | 117,267 | 91,303 | 57,969 |
Cost of Revenue | 2,120 | |||
Free Cash Flow | 10,164 | -16,009 | -10,971 | -7,105 |
Cash | 17,053 | 6,199 | 5,715 | 20,298 |
Basic Shares | 150,042 | 133,665 | 126,793 | 94,085 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.07 |
2026-03-31 | -$0.02 |
2025-12-31 | -$0.01 |
2025-09-30 | $0.01 |